HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Irish Tax Office Pauses Supplement Tax Thanks To Pressure From Industry

Executive Summary

Ireland halts imposition of a 23% value-added tax (VAT) on food supplements thanks in part to public campaigning by the Irish Health Trade Association (IHTA).

You may also be interested in...



Switchers, apply here, says HPRA

Irish medicines agency, the HPRA, has said it is “open” to prescription-to-OTC switch applications, especially if they are first-in-category switches, and will offer advice to firms that apply.

Rowex launches OTC sumatriptan in Ireland

Migraine sufferers in Ireland will for the first time be able to access a sumatriptan product without a prescription thanks to the OTC launch of Rowex’s Sumatran Relief.

Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches

UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel